Private Advisor Group’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$336K Hold
47,583
﹤0.01% 2116
2025
Q4
$236K Hold
47,583
﹤0.01% 2305
2025
Q3
$215K Hold
47,583
﹤0.01% 2297
2025
Q2
$148K Hold
47,583
﹤0.01% 2280
2025
Q1
$119K Hold
47,583
﹤0.01% 2178
2024
Q4
$148K Hold
47,583
﹤0.01% 2141
2024
Q3
$113K Hold
47,583
﹤0.01% 2294
2024
Q2
$120K Sell
47,583
-10,847
-19% -$27.6K ﹤0.01% 2215
2024
Q1
$172K Hold
58,430
﹤0.01% 2146
2023
Q4
$176K Buy
+58,430
New +$188K ﹤0.01% 2063

Other funds holding DRTS

Private Advisor Group's DRTS Position: Q1 2026 in Review

Private Advisor Group held its Alpha Tau Medical (DRTS) position steady in Q1 2026 at 47,583 shares worth $336K. The position accounts for ﹤0.01% of the portfolio, ranked #2116.

Private Advisor Group first reported a position in DRTS in Q4 2023 and has held it in 10 quarters since. 53 funds tracked by Wall St. Rank hold DRTS as of Q1 2026.

  • Private Advisor Group held 47,583 shares of Alpha Tau Medical worth $336K as of Q1 2026.
  • Private Advisor Group left its Alpha Tau Medical share count unchanged in Q1 2026.
  • Alpha Tau Medical made up ﹤0.01% of Private Advisor Group's portfolio in Q1 2026, its #2116 holding.
  • Private Advisor Group first reported a position in Alpha Tau Medical in Q4 2023 and has held it in 10 quarters since.
  • 53 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.